scispace - formally typeset
Journal ArticleDOI

In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.

Reads0
Chats0
TLDR
The results suggest that AS057278 has the potential to anti-psychotic action toward both cognitive and positive symptoms of schizophrenia.
About
This article is published in European Neuropsychopharmacology.The article was published on 2008-03-01. It has received 126 citations till now. The article focuses on the topics: Phencyclidine & Agonist.

read more

Citations
More filters
Journal ArticleDOI

Realistic expectations of prepulse inhibition in translational models for schizophrenia research

TL;DR: This review enumerates the realistic expectations for PPI in translational models for schizophrenia research, and provides cautionary notes for the future applications of this important research tool.
Journal ArticleDOI

Add-on Treatment of Benzoate for Schizophrenia: A Randomized, Double-blind, Placebo-Controlled Trial of d-Amino Acid Oxidase Inhibitor

TL;DR: Benzoate adjunctive therapy significantly improved a variety of symptom domains and neurocognition in patients with chronic schizophrenia and the preliminary results show promise for d-amino acid oxidase inhibition as a novel approach for new drug development for schizophrenia.
Journal ArticleDOI

The neurobiology of D -amino acid oxidase and its involvement in schizophrenia

TL;DR: This review critically review the neurobiology of DAO, its involvement in schizophrenia, and the therapeutic value ofDAO inhibition and highlights issues that have a broader relevance beyond DAO itself.
References
More filters
Journal ArticleDOI

New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening

TL;DR: The SRB assay provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-volume, automated drug screening.
Journal ArticleDOI

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

TL;DR: These data indicate that N-methyl-D-aspartate antagonists produce a broad range of symptoms, behaviors, and cognitive deficits that resemble aspects of endogenous psychoses, particularly schizophrenia and dissociative states.
Journal ArticleDOI

Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia.

TL;DR: A heuristic framework for linking the psychological and biological in psychosis is provided and it is proposed that a dysregulated, hyperdopaminergic state, at a "brain" level of description and analysis, leads to an aberrant assignment of salience to the elements of one's experience, at an "mind" level.
Journal ArticleDOI

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

TL;DR: A review of the literature on prepulse inhibition (PPI) in humans can be found in this article, where a relatively weak sensory event (the prepulse) is presented 30-500 ms before a strong startle-inducing stimulus, and reduces the magnitude of the startle response.
Journal ArticleDOI

Sensorimotor Gating and Schizophrenia: Human and Animal Model Studies

TL;DR: Human and animal model studies of sensorimotor gating allow investigators to comment on the spatial and temporal mapping of neurons, trait and state deficits, and vulnerability factors in the schizophrenic spectrum of disorders.
Related Papers (5)